Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process. (Q39640530)
Jump to navigation
Jump to search
scientific article published on 22 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process. |
scientific article published on 22 October 2010 |
Statements
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process (English)
Gatien Moriceau
Benjamin Ory
Laura Mitrofan
Régis Brion
Céline Charrier
Séverine Battaglia
Paul Pilet
Leonard D Shultz
Jukka Mönkkönen
Françoise Rédini
Dominique Heymann
22 October 2010
1 reference
1 reference
1 reference